CFG
NDRA icon

Citizens Financial Group’s ENDRA Life Sciences NDRA Stock Holding History

Citizens Financial Group’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Buy
+28,400
New +$144K ﹤0.01% 1016

Other funds holding NDRA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Citizens Financial Group's NDRA Position: Q2 2026 in Review

Citizens Financial Group opened a new position in ENDRA Life Sciences (NDRA) in Q2 2026: 28,400 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #1016 among its holdings.

9 funds tracked by Wall St. Rank hold NDRA as of Q2 2026.

  • Citizens Financial Group held 28,400 shares of ENDRA Life Sciences worth $151K as of Q2 2026.
  • ENDRA Life Sciences was a new Citizens Financial Group position in Q2 2026.
  • ENDRA Life Sciences made up ﹤0.01% of Citizens Financial Group's portfolio in Q2 2026, its #1016 holding.
  • 9 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.